• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Inflammasomes: Threat-Assessment Organelles of the Innate Immune System.炎症小体:先天免疫系统的威胁评估细胞器。
Immunity. 2019 Oct 15;51(4):609-624. doi: 10.1016/j.immuni.2019.08.005. Epub 2019 Aug 28.
2
Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling.无偶联的细胞焦亡和白介素-1β 分泌下游的炎症小体信号通路。
Front Immunol. 2023 Apr 6;14:1128358. doi: 10.3389/fimmu.2023.1128358. eCollection 2023.
3
Inflammasomes and their roles in health and disease.炎症小体及其在健康和疾病中的作用。
Annu Rev Cell Dev Biol. 2012;28:137-61. doi: 10.1146/annurev-cellbio-101011-155745. Epub 2012 Sep 10.
4
Bacterial recognition pathways that lead to inflammasome activation.导致炎性小体激活的细菌识别途径。
Immunol Rev. 2015 May;265(1):112-29. doi: 10.1111/imr.12289.
5
Mechanisms governing inflammasome activation, assembly and pyroptosis induction.调控炎症小体激活、组装和细胞焦亡诱导的机制。
Int Immunol. 2017 May 1;29(5):201-210. doi: 10.1093/intimm/dxx018.
6
Regulation of inflammasome activation.炎性小体激活的调控
Immunol Rev. 2015 May;265(1):6-21. doi: 10.1111/imr.12296.
7
The nucleic acid-sensing inflammasomes.核酸感应炎性小体。
Immunol Rev. 2015 May;265(1):103-11. doi: 10.1111/imr.12281.
8
NLRP7 and related inflammasome activating pattern recognition receptors and their function in host defense and disease.NLRP7 及相关炎性小体激活模式识别受体及其在宿主防御和疾病中的功能。
Microbes Infect. 2013 Jul-Aug;15(8-9):630-9. doi: 10.1016/j.micinf.2013.04.001. Epub 2013 Apr 22.
9
Regulation of inflammasome signaling.炎症小体信号的调控。
Nat Immunol. 2012 Mar 19;13(4):333-42. doi: 10.1038/ni.2237.
10
Intracellular sensing of microbes and danger signals by the inflammasomes.炎症小体对微生物和危险信号的细胞内感知。
Immunol Rev. 2011 Sep;243(1):119-35. doi: 10.1111/j.1600-065X.2011.01050.x.

引用本文的文献

1
Mitigation of sepsis-induced liver injury by Clemastine via modulating GSDMD/NLRP-3/Caspase-1/NF-κB signalling pathways.氯马斯汀通过调节GSDMD/NLRP-3/半胱天冬酶-1/核因子κB信号通路减轻脓毒症诱导的肝损伤
Eur J Med Res. 2025 Aug 6;30(1):715. doi: 10.1186/s40001-025-02982-w.
2
Clustering of NLRP3 induced by membrane or protein scaffolds promotes inflammasome assembly.由膜或蛋白质支架诱导的NLRP3聚集促进炎性小体组装。
Nat Commun. 2025 May 27;16(1):4887. doi: 10.1038/s41467-025-60277-4.
3
Endothelial Dysfunction: Redox Imbalance, NLRP3 Inflammasome, and Inflammatory Responses in Cardiovascular Diseases.内皮功能障碍:氧化还原失衡、NLRP3炎性小体与心血管疾病中的炎症反应
Antioxidants (Basel). 2025 Feb 23;14(3):256. doi: 10.3390/antiox14030256.
4
Progress in cytokine research for ARDS: A comprehensive review.急性呼吸窘迫综合征细胞因子研究进展:综述
Open Med (Wars). 2024 Oct 28;19(1):20241076. doi: 10.1515/med-2024-1076. eCollection 2024.
5
Role for NLRP3 inflammasome-mediated, Caspase1-dependent response in glaucomatous trabecular meshwork cell death and regulation of aqueous humor outflow.NLRP3炎性小体介导的、半胱天冬酶1依赖性反应在青光眼小梁网细胞死亡及房水流出调节中的作用。
Heliyon. 2024 Sep 25;10(19):e38258. doi: 10.1016/j.heliyon.2024.e38258. eCollection 2024 Oct 15.
6
Inflammasome protein scaffolds the DNA damage complex during tumor development.炎症小体蛋白在肿瘤发展过程中作为 DNA 损伤复合物的支架。
Nat Immunol. 2024 Nov;25(11):2085-2096. doi: 10.1038/s41590-024-01988-6. Epub 2024 Oct 14.
7
Activation of the NLRP1B inflammasome by caspase-8.NLRP1B 炎性小体被半胱天冬酶-8 激活。
Commun Biol. 2024 Sep 17;7(1):1164. doi: 10.1038/s42003-024-06882-3.
8
Novel cortisol trajectory sub-phenotypes in sepsis.脓毒症中新型皮质醇轨迹亚表型。
Crit Care. 2024 Sep 3;28(1):290. doi: 10.1186/s13054-024-05071-2.
9
Cyclic GMP-AMP synthase recognizes the physical features of DNA.环状GMP-AMP合酶识别DNA的物理特征。
Acta Pharmacol Sin. 2025 Feb;46(2):264-270. doi: 10.1038/s41401-024-01369-7. Epub 2024 Aug 7.
10
Targeting NLRP3 Inflammasomes: A Trojan Horse Strategy for Intervention in Neurological Disorders.靶向NLRP3炎性小体:一种干预神经疾病的木马策略。
Mol Neurobiol. 2025 Feb;62(2):1840-1881. doi: 10.1007/s12035-024-04359-2. Epub 2024 Jul 23.

本文引用的文献

1
Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome.NEK7 许可激活 NLRP3 炎症小体的结构机制。
Nature. 2019 Jun;570(7761):338-343. doi: 10.1038/s41586-019-1295-z. Epub 2019 Jun 12.
2
Cell Survival and Cytokine Release after Inflammasome Activation Is Regulated by the Toll-IL-1R Protein SARM.炎性小体激活后细胞存活和细胞因子释放受 Toll-IL-1R 蛋白 SARM 调节。
Immunity. 2019 Jun 18;50(6):1412-1424.e6. doi: 10.1016/j.immuni.2019.04.005. Epub 2019 May 7.
3
The NLRP3 inflammasome: molecular activation and regulation to therapeutics.NLRP3 炎性小体:分子激活与治疗调控。
Nat Rev Immunol. 2019 Aug;19(8):477-489. doi: 10.1038/s41577-019-0165-0.
4
Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly.外在和内在凋亡途径激活连接蛋白-1 以驱动 NLRP3 炎性小体组装。
EMBO J. 2019 May 15;38(10). doi: 10.15252/embj.2019101638. Epub 2019 Mar 22.
5
Functional degradation: A mechanism of NLRP1 inflammasome activation by diverse pathogen enzymes.功能退化:多种病原体酶激活 NLRP1 炎性体的机制。
Science. 2019 Apr 5;364(6435). doi: 10.1126/science.aau1330. Epub 2019 Mar 14.
6
N-terminal degradation activates the NLRP1B inflammasome.N 端降解激活 NLRP1B 炎性小体。
Science. 2019 Apr 5;364(6435):82-85. doi: 10.1126/science.aau1208. Epub 2019 Mar 14.
7
Innate Immune Signaling Organelles Display Natural and Programmable Signaling Flexibility.先天免疫信号细胞器显示天然和可编程的信号灵活性。
Cell. 2019 Apr 4;177(2):384-398.e11. doi: 10.1016/j.cell.2019.01.039. Epub 2019 Mar 7.
8
Macrophages, rather than DCs, are responsible for inflammasome activity in the GM-CSF BMDC model.在 GM-CSF BMDC 模型中,负责炎性小体活性的是巨噬细胞,而不是树突状细胞。
Nat Immunol. 2019 Apr;20(4):397-406. doi: 10.1038/s41590-019-0313-5. Epub 2019 Feb 11.
9
Leishmania Lipophosphoglycan Triggers Caspase-11 and the Non-canonical Activation of the NLRP3 Inflammasome.利什曼原虫脂磷聚糖触发半胱天冬酶-11 和 NLRP3 炎性小体的非经典激活。
Cell Rep. 2019 Jan 8;26(2):429-437.e5. doi: 10.1016/j.celrep.2018.12.047.
10
Inflammasome and Caspase-1 Activity Characterization and Evaluation: An Imaging Flow Cytometer-Based Detection and Assessment of Inflammasome Specks and Caspase-1 Activation.炎症小体和半胱天冬酶-1 活性的表征和评估:基于成像流式细胞仪的炎症小体斑点和半胱天冬酶-1 激活的检测和评估。
J Immunol. 2019 Feb 1;202(3):1003-1015. doi: 10.4049/jimmunol.1800973. Epub 2018 Dec 31.

炎症小体:先天免疫系统的威胁评估细胞器。

Inflammasomes: Threat-Assessment Organelles of the Innate Immune System.

机构信息

Division of Gastroenterology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Program in Immunology, Harvard Medical School, Boston, MA 02115, USA.

Division of Gastroenterology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Program in Immunology, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Immunity. 2019 Oct 15;51(4):609-624. doi: 10.1016/j.immuni.2019.08.005. Epub 2019 Aug 28.

DOI:10.1016/j.immuni.2019.08.005
PMID:31473100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6801093/
Abstract

Inflammasomes are supramolecular organizing centers that operate to drive interleukin-1 (IL-1)-dependent inflammation. Depending on context, inflammatory caspases act upstream or downstream of inflammasome assembly, serving as the principal enzymes that control activities of these organelles. In this review, we discuss mechanisms of inflammasome assembly and signaling. We posit that upstream regulatory proteins, classically known as pattern-recognition receptors, operate to assess infectious and non-infectious threats to the host. Threat assessment is achieved through two general strategies: (1) direct binding of receptors to microbial or host-derived ligands or (2) indirect detection of changes in cellular homeostasis. Upon activation, these upstream regulatory factors seed the assembly of inflammasomes, leading to IL-1 family cytokine release from living (hyperactive) or dead (pyroptotic) cells. The molecular and physiological consequences of these distinct cell fate decisions are discussed.

摘要

炎症小体是一种超分子组装中心,可驱动白细胞介素-1(IL-1)依赖性炎症。根据具体情况,炎性半胱天冬酶在上游或炎症小体组装的下游起作用,作为控制这些细胞器活性的主要酶。在这篇综述中,我们讨论了炎症小体的组装和信号转导机制。我们假设上游调节蛋白,通常称为模式识别受体,用于评估宿主受到的感染和非感染威胁。威胁评估是通过两种一般策略实现的:(1)受体与微生物或宿主来源的配体直接结合,或(2)间接检测细胞内稳态的变化。在激活后,这些上游调节因子引发炎症小体的组装,导致活(过度活跃)或死(细胞焦亡)细胞释放白细胞介素-1 家族细胞因子。讨论了这些不同细胞命运决定的分子和生理后果。